Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Molecular Relapse in Pediatric AML: Clinical Relapse May be Predicted By Increasingin MRD Level - Experiences from Real-World Data in Patients with Inv(16), t(8;21), t(9;11), t(10;11) or NPM1

Katharina Waack, Katharina Andernacht, Christiane Walter, Markus Schneider, Nils Von Neuhoff, Sophia Hahn, Amani Awada, Dirk Reinhardt

Blood (2022) 140 (Supplement 1): 6326–6327.

https://doi.org/10.1182/blood-2022-169495

Published: 2022

Journal Articles

Downregulation of the Mutated WT1 Alleles in Malignant Hematopoietic Cells Via Nonsense-Mediated mRNA Decay Contradicts Their Prognostic Impact

Lisa Weber, Christiane Walter, Markus Schneider, Hans Günther Drexler, Dirk Reinhardt, Helmut Hanenberg, Naghmeh Niktoreh

Blood (2022) 140 (Supplement 1): 11498–11499.

https://doi.org/10.1182/blood-2022-168591

Published: 2022

Journal Articles

Failures and Successes in Pediatric Patients with Acute Myeloid Leukemia with First Relapse: A Large International Report on Current Treatment Strategies and Outcome

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141774

Published: 2020

Journal Articles

Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group

Martina Pigazzi, PhD, Maddalena Benetton, Christiane Walter, MSc, Maria Hansen, Anne-Sofie Skou, MD, Ambra Da Ros, Anna Marchetti, Katia Polato, Mattia Belloni, Claudia Tregnago, PhD, Jonas Abrahamsson, MD PhD, Linda Fogelstrand, Nils Von Neuhoff, PhD, Dirk Reinhardt, MDPhD, Henrik Hasle, PhD, Franco Locatelli, MD, Pietro Merli, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-137424

Published: 2020

Journal Articles

Improved Outcome in Pediatric AML - the AML-BFM 2012 Study

Katharina Waack, Markus Schneider, PhD, Christiane Walter, MSc, Ursula Creutzig, MD, Jan-Henning Klusmann, Mareike Rasche, MD, Heidrun Boztug, Katharina Jansen, PhD, Gabriele Escherich, MD, Michael Frühwald, MD, Michael Dworzak, MD PhD, Dirk Reinhardt, MD

Blood (2020) 136 (Supplement 1): 12–14.

https://doi.org/10.1182/blood-2020-139189

Published: 2020

Journal Articles

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group

Mareike Rasche, MD, Emma Steidel, Martin Zimmermann, Jean-Pierre Bourquin, MD PhD, Heidrun Boztug, Iveta Janotová, Edward A. Kolb, MD, Thomas Lehrnbecher, Nils Von Neuhoff, PhD, Naghmeh Niktoreh, Nora Muehlegger, Lucie Sramkova, MD, Jan Stary, MD PhD, Christiane Walter, MSc, Ursula Creutzig, MD PhD, Michael Dworzak, MD PhD, Dirk Reinhardt, MD

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-139317

Published: 2020

Journal Articles

Treatment‐Related Acute Myeloid Leukemia in Children

Katharina Waack, Katharina Röllecke, PhD, Mareike Rasche, MD, Christiane Walter, MSc, Ursula Creutzig, MD PhD, Dirk Reinhardt, MD PhD

Blood (2019) 134 (Supplement_1): 1322.

https://doi.org/10.1182/blood-2019-131911

Published: 2019

Journal Articles

Mutational Landscape of Pediatric Acute Myeloid Leukemia: A Report of the AML-BFM Study Group with a Targeted NGS Approach in 525 Patients Integrating De Novo, Relapsed and Secondary AML

Christiane Walter, MSc, Markus Schneider, PhD, Nils Von Neuhoff, PhD, Helmut Hanenberg, MD, Dirk Reinhardt, MD, Mareike Rasche, MD

Blood (2019) 134 (Supplement_1): 1398.

https://doi.org/10.1182/blood-2019-129778

Published: 2019

Journal Articles

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

Kristian Juul-Dam, MD, Hans Beier Ommen, Charlotte Guldborg Nyvold, Christiane Walter, Helen Vålerhaugen, Veli Kairisto, Jonas Abrahamsson, Sofie Johansson Alm, Kirsi Jahnukainen, Birgitte Lausen, Dirk Reinhardt, Bernward Zeller, Nils Von Neuhoff, Linda Fogelstrand, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 2754.

https://doi.org/10.1182/blood-2018-99-119642

Published: 2018

Journal Articles

Amplicon Based Panel Targeted Resequencing Identified ZRSR2 As a Potential New Favorable Marker in Pediatric AML

Christiane Walter, MSc, Zhenyu Xu, PhD, Martin Zimmermann, PhD, Dirk Reinhardt, MD PhD, Nils Von Neuhoff, PhD

Blood (2016) 128 (22): 2905.

https://doi.org/10.1182/blood.V128.22.2905.2905

Published: 2016

Journal Articles

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Nils von Neuhoff, PhD, Peter Husemann, PhD, Robert Geffers, PhD, Christiane Walter, M.Sc., Christine von Neuhoff, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 2340.

https://doi.org/10.1182/blood.V124.21.2340.2340

Published: 2014

Journal Articles

Mimicking the Bone Marrow Niche in Vitro : Establishment of a 3D Perfusion Culture System for Mesenchymal Stromal Cells

Lika Drakhlis, B.Sc., Christiane Walter, M.Sc., Maike Hinrichs, PhD, Katarina Reinhardt, PhD, Dirk Reinhardt, MD PhD, Nils von Neuhoff, PhD

Blood (2014) 124 (21): 5136.

https://doi.org/10.1182/blood.V124.21.5136.5136

Published: 2014

Journal Articles

Single Cell Whole Exome Sequencing in NPM1/Flt3 Positive Pediatric Acute Myeloid Leukemia

Christiane Walter, M.Sc., Winfried Hofmann, Dr. rer. nat., Katarina Reinhardt, PhD, Dirk Reinhardt, MD PhD, Nils von Neuhoff, PhD

Blood (2014) 124 (21): 1043.

https://doi.org/10.1182/blood.V124.21.1043.1043

Published: 2014

NARROW

Molecular Relapse in Pediatric AML: Clinical Relapse May be Predicted By Increasingin MRD Level - Experiences from Real-World Data in Patients with Inv(16), t(8;21), t(9;11), t(10;11) or NPM1

Downregulation of the Mutated WT1 Alleles in Malignant Hematopoietic Cells Via Nonsense-Mediated mRNA Decay Contradicts Their Prognostic Impact

Failures and Successes in Pediatric Patients with Acute Myeloid Leukemia with First Relapse: A Large International Report on Current Treatment Strategies and Outcome

Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group

Improved Outcome in Pediatric AML - the AML-BFM 2012 Study

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group

Treatment‐Related Acute Myeloid Leukemia in Children

Mutational Landscape of Pediatric Acute Myeloid Leukemia: A Report of the AML-BFM Study Group with a Targeted NGS Approach in 525 Patients Integrating De Novo, Relapsed and Secondary AML

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

Amplicon Based Panel Targeted Resequencing Identified ZRSR2 As a Potential New Favorable Marker in Pediatric AML

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Mimicking the Bone Marrow Niche in Vitro : Establishment of a 3D Perfusion Culture System for Mesenchymal Stromal Cells

Single Cell Whole Exome Sequencing in NPM1/Flt3 Positive Pediatric Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only